Journal of Gastric Cancer

The Korean Gastric Cancer Association (대한위암학회)
권호 표지
DOI QR코드

DOI QR Code

Influence of Helicobacter pylori Infection on Endoscopic Findings of Gastric Adenocarcinoma of the Fundic Gland Type

  • Received : 2019.03.21
  • Accepted : 2019.06.06
  • Published : 2019.06.28
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Gastric adenocarcinoma of the fundic gland type (chief cell predominant type) (GA-FG-CCP) was first reported as a rare adenocarcinoma found in the normal fundic mucosa. Recent studies have proposed the possibility that GA-FG-CCPs were also generated in the atrophic mucosa after Helicobacter pylori (HP) eradication therapy. However, little is known on the endoscopic findings of GA-FG-CCP generated in the atrophic mucosa due to its extreme rarity. Materials and Methods: A total of 8 patients who underwent endoscopic submucosal resection and were diagnosed with GA-FG-CCP generated in the HP-uninfected mucosa (4 cases, HP-uninfected group) or HP-eradicated atrophic mucosa (4 cases, HP-eradicated group) were retrospectively analyzed, and their endoscopic findings, including magnifying endoscopy with narrow band imaging (M-NBI), and pathological features were compared. Results: While GA-FG-CCPs in the 2 groups displayed similar macroscopic appearance, M-NBI demonstrated that characteristic microvessels (tapered microvessels like withered branches) were specifically identified in the HP-eradicated group. Pathological investigation revealed that a decreasing number of fundic glands and thinned foveolar epithelium covering tumor ducts were thought to lower the thickness of the covering layer over tumor ducts in the HP-eradicated group. Moreover, dilation of vessels just under the surface of the lesions contributed to the visualization of microvessels by M-NBI. Conclusions: The change in background mucosa due to HP infection influenced the thickness of the covering layer over the tumor ducts and M-NBI finding of GA-FG-CCP.

Keywords

References

  1. Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001;49:347-353. https://doi.org/10.1136/gut.49.3.347
  2. Wang C, Yuan Y, Hunt RH. The association between Helicobacter pylori infection and early gastric cancer: a meta-analysis. Am J Gastroenterol 2007;102:1789-1798. https://doi.org/10.1111/j.1572-0241.2007.01335.x
  3. Nakamura K, Sugano H, Takagi K. Carcinoma of the stomach in incipient phase: its histogenesis and histological appearances. Gan 1968;59:251-258.
  4. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. an attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965;64:31-49. https://doi.org/10.1111/apm.1965.64.1.31
  5. Moss SF. The clinical evidence linking Helicobacter pylori to gastric cancer. Cell Mol Gastroenterol Hepatol 2016;3:183-191. https://doi.org/10.1016/j.jcmgh.2016.12.001
  6. Ueyama H, Yao T, Nakashima Y, Hirakawa K, Oshiro Y, Hirahashi M, et al. Gastric adenocarcinoma of fundic gland type (chief cell predominant type): proposal for a new entity of gastric adenocarcinoma. Am J Surg Pathol 2010;34:609-619. https://doi.org/10.1097/PAS.0b013e3181d94d53
  7. Ueyama H, Matsumoto K, Nagahara A, Hayashi T, Yao T, Watanabe S. Gastric adenocarcinoma of the fundic gland type (chief cell predominant type). Endoscopy 2014;46:153-157. https://doi.org/10.1055/s-0034-1364955
  8. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma. 15th ed. Tokyo: Kanehara Shuppan, 2017.
  9. Miyazawa M, Matsuda M, Yano M, Hara Y, Arihara F, Horita Y, et al. Gastric adenocarcinoma of the fundic gland (chief cell-predominant type): a review of endoscopic and clinicopathological features. World J Gastroenterol 2016;22:10523-10531. https://doi.org/10.3748/wjg.v22.i48.10523
  10. Miyazawa M, Matsuda M, Yano M, Hara Y, Arihara F, Horita Y, et al. Gastric adenocarcinoma of fundic gland type: five cases treated with endoscopic resection. World J Gastroenterol 2015;21:8208-8214. https://doi.org/10.3748/wjg.v21.i26.8208
  11. Okumura Y, Takamatsu M, Ohashi M, Yamamoto Y, Yamamoto N, Kawachi H, et al. Gastric adenocarcinoma of fundic gland type with aggressive transformation and lymph node metastasis: a case report. J Gastric Cancer 2018;18:409-416. https://doi.org/10.5230/jgc.2018.18.e22
  12. Chiba T, Kato K, Masuda T, Ohara S, Iwama N, Shimada T, et al. Clinicopathological features of gastric adenocarcinoma of the fundic gland (chief cell predominant type) by retrospective and prospective analyses of endoscopic findings. Dig Endosc 2016;28:722-730. https://doi.org/10.1111/den.12676
  13. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 2011;14:101-112. https://doi.org/10.1007/s10120-011-0041-5
  14. Sano T, Aiko T. New Japanese classifications and treatment guidelines for gastric cancer: revision concepts and major revised points. Gastric Cancer 2011;14:97-100. https://doi.org/10.1007/s10120-011-0040-6
  15. Yao K, Iwashita A, Matsui T. A new diagnostic VS classification system produced by magnification endoscopy plus narrow-band imaging in the stomach: microvascular architecture and microsurface structure. In: Niwa H, Tajiri H, Nakajima M, Yasuda K, eds. New Challenges in Gastrointestinal Endoscopy. Tokyo: Springer, 2008:169-176.
  16. Yao K, Anagnostopoulos GK, Ragunath K. Magnifying endoscopy for diagnosing and delineating early gastric cancer. Endoscopy 2009;41:462-467. https://doi.org/10.1055/s-0029-1214594
  17. Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy 1969;1:87-97. https://doi.org/10.1055/s-0028-1098086
  18. Nagahama T, Yao K, Maki S, Yasaka M, Takaki Y, Matsui T, et al. Usefulness of magnifying endoscopy with narrow-band imaging for determining the horizontal extent of early gastric cancer when there is an unclear margin by chromoendoscopy (with video). Gastrointest Endosc 2011;74:1259-1267. https://doi.org/10.1016/j.gie.2011.09.005
  19. Ezoe Y, Muto M, Uedo N, Doyama H, Yao K, Oda I, et al. Magnifying narrowband imaging is more accurate than conventional white-light imaging in diagnosis of gastric mucosal cancer. Gastroenterology 2011;141:2017-2025.e3. https://doi.org/10.1053/j.gastro.2011.08.007
  20. Muto M, Yao K, Kaise M, Kato M, Uedo N, Yagi K, et al. Magnifying endoscopy simple diagnostic algorithm for early gastric cancer (MESDA-G). Dig Endosc 2016;28:379-393. https://doi.org/10.1111/den.12638

Cited by

  1. Quality Indicators for the Detection of Helicobacter pylori -Negative Early Gastric Cancer: A Retrospective Observational Study vol.53, pp.6, 2020, https://doi.org/10.5946/ce.2019.203
  2. CagA orchestrates eEF1A1 and PKCδ to induce interleukin-6 expression in Helicobacter pylori -infected gastric epithelial cells vol.12, 2019, https://doi.org/10.1186/s13099-020-00368-3
  3. Gastric adenocarcinoma of the fundic gland: A review of clinicopathological characteristics, treatment and prognosis vol.13, 2019, https://doi.org/10.1177/20363613211060171
  4. Helicobacter pylori-negative Gastric Cancer vol.21, pp.1, 2019, https://doi.org/10.7704/kjhugr.2020.0036
  5. Long-term Observation of Gastric Adenocarcinoma of Fundic Gland Mucosa Type before and after Helicobacter pylori Eradication: a Case Report vol.21, pp.1, 2019, https://doi.org/10.5230/jgc.2021.21.e11
  6. Quality management system for screening esophagogastroduodenoscopy improves detection of Helicobacter pylori-negative interval gastric cancer vol.9, pp.12, 2019, https://doi.org/10.1055/a-1594-1833